These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 176436)

  • 1. Characterization of Epstein-Barr virus antigens. I. Biochemical analysis of the complement-fixing soluble antigen and relationship with Epstein-Barr virus-associated nuclear antigen.
    Lenoir G; Berthelon MC; Favre MC; de-Thé G
    J Virol; 1976 Feb; 17(2):672-4. PubMed ID: 176436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification of the Epstein-Barr virus nuclear antigen(s).
    Sculley TB; Kreofsky T; Pearson GR; Spelsberg TC
    J Biol Chem; 1983 Mar; 258(6):3974-82. PubMed ID: 6300065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit.
    Luka J; Jörnvall H; Klein G
    J Virol; 1980 Sep; 35(3):592-602. PubMed ID: 6158579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines.
    Luka J; Lindahl T; Klein G
    J Virol; 1978 Sep; 27(3):604-11. PubMed ID: 212583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence.
    Klein G; Vonka V
    J Natl Cancer Inst; 1974 Dec; 53(6):1645-6. PubMed ID: 4373574
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of Epstein-Barr virus-determined nuclear antigen (EBNA) by chromatography on fixed cell nuclei.
    Hirsch I; Suchánková A; Závadová H; Vonka V
    Int J Cancer; 1978 Nov; 22(5):535-41. PubMed ID: 82540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes.
    Ohno S; Luka J; Lindahl T; Klein G
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1605-9. PubMed ID: 67603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble complement fixing antigens in Epstein-Barr virus cell systems.
    Twardzik DR; Ablashi DV; Easton JM; Armstrong GR
    Bibl Haematol; 1975 Oct; (43):412-6. PubMed ID: 183710
    [No Abstract]   [Full Text] [Related]  

  • 9. Solubilisation of Epstein-Barr virus (EBV)-associated nuclear antigen from Raji cells and chromatin by treatment with various molarities of NaCl.
    Brown TD; Rickwood D; MacGillivray AJ; Klein G
    Cancer Lett; 1977 Sep; 3(3-4):151-6. PubMed ID: 198113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis.
    Strnad BC; Schuster TC; Hopkins RF; Neubauer RH; Rabin H
    J Virol; 1981 Jun; 38(3):996-1004. PubMed ID: 7017165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on Epstein-Barr virus-related antigens. II. Biochemical properties of soluble antigen in Raji Burkitt lymphoma cells.
    Matsuo T; Nishi S; Hirai H; Osato T
    Int J Cancer; 1977 Mar; 19(3):364-70. PubMed ID: 14897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the expression of two Epstein-Barr virus-associated antigens, EBNA and RANA, during the cell cycle of transformed human B lymphoblasts.
    Slovin SF; Vaughan JH; Carson DA
    Int J Cancer; 1980 Jul; 26(1):9-12. PubMed ID: 6263806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of Epstein-Barr virus (EBV)-associated nuclear antigen: solubilization from Raji cell chromatin with 5 M-urea-2 M-nacl and fractionation on hydroxyapatite.
    Brown TD; Rickwood D; MacGillivray AJ; Klein G
    J Gen Virol; 1978 Sep; 40(3):511-7. PubMed ID: 211194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial purification and properties of the Epstein-Barr virus-associated nuclear antigen.
    Baron D; Strominger JL
    J Biol Chem; 1978 Apr; 253(8):2875-81. PubMed ID: 204660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Epstein-Barr virus-associated nuclear antigen and cell viability in human cell lines.
    Suzuki M; Hinuma Y
    Gan; 1975 Feb; 66(1):103-5. PubMed ID: 168112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of the complement-fixing and early antigens from Epstein-Barr soluble antigen.
    Wainwright WH; Veltri RW
    J Natl Cancer Inst; 1977 Apr; 58(4):1111-3. PubMed ID: 66320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunoelectron microscopic analysis of Epstein-Barr virus-associated complement-fixing antigen.
    Shamoto M; Suzuki I
    Cancer; 1976 Nov; 38(5):2057-64. PubMed ID: 186178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive method to detect non-complement-fixing antibodies to Epstein-Barr virus nuclear antigne.
    Schmitz H; Kampa D; Heidenreich W
    Int J Cancer; 1975 Dec; 16(6):1030-4. PubMed ID: 172458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.